MedTrace Logo

Santyl vs. Sharp Debridement of Diabetic Foot Wounds

NCT01056198 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2012-11-21

Study results available
· View outcomes & findings →

Summary

This study tests two different approaches to the removal of dead tissue from the surface of a wound.

Conditions

  • Diabetic Foot Ulcers
  • Foot Wounds

Interventions

DRUG

Santyl

2 mm Santyl applied once daily.

PROCEDURE

Control

Daily gauze and optional sharp debridement

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint, Ltd.

  • Herbert B Slade, MD · Healthpoint, Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-08-31
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056198 on ClinicalTrials.gov